Cited by 59

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Application of bio-orthogonal proteome labeling to cell transplantation and heterochronic parabiosis.

Liu, Yan, Conboy, Michael J., Mehdipour, Melod, Liu, Yutong, Tran, Thanhtra P., Blotnick, Aaron, Rajan, Prasanna, Santos, Thalie Cavalcante, Conboy, Irina M.·2017·Nature Communications

Abstract

Studies of heterochronic parabiosis demonstrated that with age, the composition of the circulatory milieu changes in ways that broadly inhibit tissue regenerative capacity. In addition, local tissue niches have age-specific influences on their resident stem cells. Here we use bio-orthogonal proteome labeling for detecting in vivo proteins present only in transplanted myoblasts, but not in host tissue, and proteins exclusive to one young mouse and transferred during parabiosis to its old partner. We use a transgenic mouse strain that ubiquitously expresses a modified tRNA methionine synthase, metRS, which preferentially incorporates the methionine surrogate azido-nor-leucine (ANL) into newly generated proteins. Using click chemistry and a modified antibody array to detect ANL-labeled proteins, we identify several ‘young’ systemic factors in old regenerating muscle of the heterochronic parabiotic partners. Our approach enables the selective profiling of mammalian proteomes in mixed biological environments such as cell and tissue transplantation, apheresis or parabiosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00698-y

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the power simulation, when variance of independent experiments is low and difference in effect size between cohorts is high, there is no difference in Power between N=4, 8, 19, or infinity.

    “As shown in Figure 1, when the Variance of independent experiments is low and the difference in ES between the cohorts is high, e.g. as in our 2003-2020, including published and current studies on young, old and rejuvenated old cohorts [1–3, 4, 9] there is no difference in Power between N=4, 8, 19, or infinity.”

    From Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin (2020) · cites this paper as [2]

    The Results section describes a study comparing young and old mice in heterochronic parabiosis, so the paper supports its use as an example of work involving those cohorts. The Methods section reports experimental sample sizes and statistical tests, but neither it nor the retrieved passages report a power simulation or show equal power at N=4, 8, 19, and infinity. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Old human serum strongly reduced myogenic cell proliferation.

    “As demonstrated in Figure 2, old human serum strongly reduced myogenic cell proliferation (which is consistent with the effects of the old mouse serum [1, 2, 6, 7, 13]).”

    From Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin (2020) · cites this paper as [2]

    The citation is attached to the parenthetical comparison with old mouse serum; the old-human-serum result is presented as the citing authors’ own Figure 2 finding. The source paper’s Introduction (page unavailable) discusses potentially inhibitory old-blood molecules, and its Results discuss age-related inhibition of muscle repair, but neither passage reports that old human serum strongly reduced myogenic cell proliferation. Searches for old human serum and serum effects on myogenic proliferation found no such result. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 59

  1. Li, J., Han, S., Cousin, W. & Conboy, I. M. Age-specific functional epigenetic changes in p21 and p16 in injury-activated satellite cells. Stem Cells 33, 951–961 (2015). · DOI
  2. Carlson, M. E. et al. Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell 8, 676–689 (2009). · DOI · Paper page
  3. Carlson, M. E. et al. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol. Med. 1, 381–391 (2009). · DOI · Paper page
  4. Conboy, I. M. & Rando, T. A. Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle 11, 2260–2267 (2012). · DOI · Paper page
  5. Conboy, I. M., Conboy, M. J. & Rebo, J. Systemic problems: a perspective on stem cell aging and rejuvenation. Aging 7, 754–765 (2015). · DOI · Paper page
  6. Egerman, M. A. et al. GDF11 Increases with age and inhibits skeletal muscle regeneration. Cell. Metab. 22, 164–174 (2015). · DOI · Paper page
  7. Smith, S. C. et al. GDF11 does not rescue aging-related pathological hypertrophy. Circ. Res. 117, 926–932 (2015). · DOI
  8. Erdmann, I. et al. Cell-selective labelling of proteomes in Drosophila melanogaster. Nat. Commun. 6, 7521 (2015). · DOI
  9. Ngo, J. T. et al. Cell-selective metabolic labeling of proteins. Nat. Chem. Biol. 5, 715–717 (2009). · DOI
  10. Mahdavi, A. et al. Engineered aminoacyl-tRNA synthetase for cell-selective analysis of mammalian protein synthesis. J. Am. Chem. Soc. 138, 4278–4281 (2016). · DOI
  11. Stone, S. E., Glenn, W. S., Hamblin, G. D. & Tirrell, D. A. Cell-selective proteomics for biological discovery. Curr. Opin. Chem. Biol. 36, 50–57 (2017). · DOI
  12. Link, A. J. et al. Discovery of aminoacyl-tRNA synthetase activity through cell-surface display of noncanonical amino acids. Proc. Natl Acad. Sci. USA 103, 10180–10185 (2006). · DOI
  13. Yuet, K. P. et al. Cell-specific proteomic analysis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 112, 2705–2710 (2015). · DOI
  14. Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A. & Schuman, E. M. Selective identification of newly synthesized proteins in Mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc. Natl Acad. Sci. USA 103, 9482–9487 (2006). · DOI · Paper page
  15. Muller, A., Stellmacher, A., Freitag, C. E., Landgraf, P. & Dieterich, D. C. Monitoring astrocytic proteome dynamics by cell type-specific protein labeling. PLoS ONE 10, e0145451 (2015). · DOI
  16. Gauthier, N. P. et al. Cell-selective labeling using amino acid precursors for proteomic studies of multicellular environments. Nat. Methods 10, 768–773 (2013). · DOI
  17. Calve, S., Witten, A. J., Ocken, A. R. & Kinzer-Ursem, T. L. Incorporation of non-canonical amino acids into the developing murine proteome. Sci. Rep. 6, 32377 (2016). · DOI
  18. Ngo, J. T., Schuman, E. M. & Tirrell, D. A. Mutant methionyl-tRNA synthetase from bacteria enables site-selective N-terminal labeling of proteins expressed in mammalian cells. Proc. Natl Acad. Sci. USA 110, 4992–4997 (2013). · DOI
  19. McClatchy, D. B. et al. Pulsed azidohomoalanine labeling in mammals (PALM) detects changes in liver-specific LKB1 knockout mice. J. Proteome Res. 14, 4815–4822 (2015). · DOI
  20. Dieterich, D. C. et al. In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons. Nat. Neurosci. 13, 897–905 (2010). · DOI
  21. Lepper, C., Conway, S. J. & Fan, C. M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 460, 627–631 (2009). · DOI
  22. Brockmann, G. A. et al. QTLs for pre- and postweaning body weight and body composition in selected mice. Mamm. Genome 15, 593–609 (2004). · DOI
  23. Wiesmann, F. et al. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. Am. J. Physiol. Heart Circ. Physiol. 278, H652–H657 (2000). · DOI
  24. Conboy, M. J. & Conboy, I. M. Preparation of adult muscle fiber-associated stem/precursor cells. Methods Mol. Biol. 621, 149–163 (2010). · DOI
  25. Paliwal, P. & Conboy, I. M. Inhibitors of tyrosine phosphatases and apoptosis reprogram lineage-marked differentiated muscle to myogenic progenitor cells. Chem. Biol. 18, 1153–1166 (2011). · DOI
  26. Yousef, H. et al. Systemic attenuation of the TGF-beta pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal. Oncotarget 6, 11959–11978 (2015). · DOI · Paper page
  27. Conboy, M. J., Cerletti, M., Wagers, A. J. & Conboy, I. M. Immuno-analysis and FACS sorting of adult muscle fiber-associated stem/precursor cells. Methods Mol. Biol. 621, 165–173 (2010). · DOI
  28. Charville, G. W. et al. Ex vivo expansion and in vivo self-renewal of human muscle stem cells. Stem Cell Rep. 5, 621–632 (2015). · DOI
  29. Naito, A. T. et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 149, 1298–1313 (2012). · DOI · Paper page
  30. Lee, H. J. et al. Kalirin, a GEF for Rac1, plays an important role in FSTL-1-mediated glucose uptake in skeletal muscle cells. Cell Signal. 29, 150–157 (2017). · DOI
  31. Rodriguez, A., Becerril, S., Ezquerro, S., Mendez-Gimenez, L. & Fruhbeck, G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol. 219, 362–381 (2017). · DOI
  32. Horsley, V., Jansen, K. M., Mills, S. T. & Pavlath, G. K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483–494 (2003). · DOI
  33. Stumhofer, J. S. & Hunter, C. A. Advances in understanding the anti-inflammatory properties of IL-27. Immunol. Lett. 117, 123–130 (2008). · DOI
  34. Barnard, W., Bower, J., Brown, M. A., Murphy, M. & Austin, L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA. J. Neurol. Sci. 123, 108–113 (1994). · DOI
  35. Price, F. D. et al. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat. Med. 20, 1174–1181 (2014). · DOI · Paper page
  36. Nicola, N. A. & Babon, J. J. Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev. 26, 533–544 (2015). · DOI · Paper page
  37. Felling, R. J., Covey, M. V., Wolujewicz, P., Batish, M. & Levison, S. W. Astrocyte-produced leukemia inhibitory factor expands the neural stem/progenitor pool following perinatal hypoxia-ischemia. J. Neurosci. Res. 94, 1531–1545 (2016). · DOI
  38. Guardiola, O. et al. Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin. Proc. Natl Acad. Sci. USA 109, E3231–E3240 (2012). · DOI
  39. Carlson, M. E., Hsu, M. & Conboy, I. M. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528–532 (2008). · DOI
  40. Macpherson, P. C., Farshi, P. & Goldman, D. Dach2-Hdac9 signaling regulates reinnervation of muscle endplates. Development 142, 4038–4048 (2015).
  41. Cruciat, C. M. & Niehrs, C. Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. 5, a015081 (2013). · DOI · Paper page
  42. Seib, D. R. et al. Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 12, 204–214 (2013). · DOI
  43. Yousef, H. et al. Age-associated increase in BMP signaling inhibits hippocampal neurogenesis. Stem Cells 33, 1577–1588 (2015). · DOI · Paper page
  44. Grimmig, B., Morganti, J., Nash, K. & Bickford, P. C. Immunomodulators as therapeutic agents in mitigating the progression of Parkinson’s disease. Brain Sci. 6, E41 (2016). · DOI · Paper page
  45. Nanki, T., Imai, T. & Kawai, S. Fractalkine/CX3CL1 in rheumatoid arthritis. Modern Rheumatol. 27, 392–397 (2017). · DOI
  46. Metcalfe, S. M. LIF in the regulation of T-cell fate and as a potential therapeutic. Genes Immun. 12, 157–168 (2011). · DOI
  47. Davis, S. M. & Pennypacker, K. R. Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke. Neurochem. Int. 107, 23–32 (2016). · DOI
  48. Kaji, H. Interaction between muscle and bone. J. Bone Metab. 21, 29–40 (2014). · DOI
  49. Zaidi, S. H., Huang, Q., Momen, A., Riazi, A. & Husain, M. Growth differentiation factor 5 regulates cardiac repair after myocardial infarction. J. Am. Coll. Cardiol. 55, 135–143 (2010). · DOI
  50. Di Raimondo, D. et al. Are the myokines the mediators of physical activity-induced health benefits? Curr. Pharm. Des. 22, 3622–3647 (2016). · DOI
  51. Chen, W. et al. Follistatin-like 1 protects cardiomyoblasts from injury induced by sodium nitroprusside through modulating Akt and Smad1/5/9 signaling. Biochem. Biophys. Res. Commun. 469, 418–423 (2016). · DOI
  52. Ouchi, N. et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J. Biol. Chem. 283, 32802–32811 (2008). · DOI · Paper page
  53. Wang, B., Chandrasekera, P. C. & Pippin, J. J. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr. Diabetes Rev. 10, 131–145 (2014). · DOI
  54. Sarmento-Cabral, A. et al. Adipokines (leptin, adiponectin, resistin) differentially regulate all hormonal cell types in primary anterior pituitary cell cultures from two primate species. Sci. Rep. 7, 43537 (2017). · DOI
  55. Rodriguez, A. et al. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice. Int. J. Obes. 39, 397–407 (2015). · DOI
  56. Balazova, L. et al. Metabolic effects of subchronic peripheral oxytocin administration in lean and obese zucker rats. J. Physiol. Pharmacol. 67, 531–541 (2016).
  57. Altirriba, J., Poher, A. L. & Rohner-Jeanrenaud, F. Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity. Front. Endocrinol. 6, 119 (2015). · DOI
  58. Perello, M. & Raingo, J. Leptin activates oxytocin neurons of the hypothalamic paraventricular nucleus in both control and diet-induced obese rodents. PLoS ONE 8, e59625 (2013). · DOI
  59. Lana, A. et al. Leptin concentration and risk of impaired physical function in older adults: the Seniors-ENRICA cohort. Age Ageing 45, 819–826 (2016). · DOI

Cited by

Sorted by citations

Metadata

Authors
Liu, Y., Conboy, M. J., Mehdipour, M., Liu, Y., Tran, T. P., Blotnick, A., Rajan, P., Santos, T. C., & Conboy, I. M.
Venue
Nature Communications
Published
2017-09-21
Volume
8
Issue
1
ISSN
2041-1723
Cited by
59
References
11
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review